Chardan Capital analyst Keay Nakae downgrades Exicure (NASDAQ:XCUR) from Buy to Neutral and lowers the price target from $2.25 to $0.4.Chardan Capital analyst Keay Nakae downgrades Exicure (NASDAQ:XCUR) from Buy to Neutral and lowers the price target from $2.25 to $0.4.
Chardan Capital Downgrades Exicure to Neutral, Lowers Price Target to $0.4
by | Dec 13, 2021 | Extra Jobs | 0 comments
Recent Comments